Strata Critical Medical (SRTA) Intangibles (2020 - 2026)

Strata Critical Medical (SRTA) has 7 years of Intangibles data on file, last reported at $46.3 million in Q1 2026.

• Intangibles for Q1 2026 came in at $46.3 million, up 242.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $46.3 million (up 242.34% YoY), and the FY2025 annual result was $47.5 million, up 496.46% from the prior year.
• Intangibles slipped to $46.3 million in Q1 2026 per SRTA's latest filing, from $47.5 million in the prior quarter.
• Over five years, Intangibles peaked at $49.8 million in Q3 2025 and troughed at $8.0 million in Q4 2024.
• A 5-year average of $30.5 million and a median of $23.7 million in 2022 frame the typical range for Intangibles.
• The sharpest annual moves came in 2022 and 2024: Intangibles jumped 1467.4% in 2022, then slumped 68.81% in 2024.
• A 5-year view of Intangibles shows it stood at $46.4 million in 2022, then slumped by 55.74% to $20.5 million in 2023, then slumped by 61.19% to $8.0 million in 2024, then soared by 496.46% to $47.5 million in 2025, then retreated by 2.51% to $46.3 million in 2026.
• Business Quant data shows SRTA's Intangibles at $46.3 million in Q1 2026, $47.5 million in Q4 2025, and $49.8 million in Q3 2025.